Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

In a Different Vein: News From the Blood Journals Portfolio

Recent research from ASH’s Blood journals

For articles on research from Blood and Blood Advances published prior to May 2024, visit Written in Blood and Blood Advances in a Different Vein.

Magrolimab Plus Azacitidine Did Not Improve Outcomes in TP53-Mutated AML Free
Leah Lawrence
May 9, 2025
Itacitinib Prophylaxis Reduces the Incidence of CRS, ICANS in IEC Therapy Free
Khylia Marshall
May 9, 2025
Cyclophosphamide May Mitigate Movement, Neurocognitive Treatment-Emergent Adverse Events Following Cilta-Cel for R/R MM Free
Katie Robinson
May 9, 2025
Analysis Identifies Best MRD Endpoint for Predicting Outcomes in NDMM Free
Leah Lawrence
May 9, 2025
Venetoclax Plus Decitabine Shows Similar Efficacy to Intensive Chemotherapy as Front- Line Therapy for Young, Fit Patients With AML Free
Anna Azvolinsky, PhD
May 1, 2025
Lenalidomide Maintenance Discontinuation a Viable Option for Some Patients With MM Free
Thomas R. Collins
May 1, 2025
PDMPs May Negatively Affect ED Uptake by People With Sickle Cell Disease Free
Ruth Jessen Hickman, MD
April 23, 2025
Detailed Analysis of TP53 Status Predicts Transplantation Outcomes in Patients With MDS/AML Free
Lara C. Pullen, PhD
April 10, 2025
DNMT3A Mutations Found in Frequent Blood Donors, But No Clonal Hematopoiesis Increase Free
Katie Robinson
April 10, 2025
Final CAVEAT Results Further Support Venetoclax Plus Intensive Chemotherapy in Older Patients With AML Free
Leah Lawrence
April 10, 2025
New Tool Aims to Improve Capture of Patient Outcomes in cGVHD-Associated Sclerosis Free
Thomas R. Collins
April 2, 2025
Front-Line Brentuximab Vedotin, Nivolumab Plus Chemotherapy Shows Durable Response, Acceptable Safety in Advanced cHL Free
Katie Robinson
April 2, 2025
Responses to BCMA CAR T Cells Not Durable in Patients with MM with CNS Involvement Free
Anna Azvolinsky, PhD
April 2, 2025
SACRED Trial Shows Utility of Hydroxyurea for Stroke Prevention in Hispanic Children with SCA Free
Ruth Jessen Hickman, MD
March 20, 2025
BCMA CAR T Cells Effective, Safe for Older Adults and Frail Patients with R/R Multiple Myeloma Free
Lara C. Pullen, PhD
March 12, 2025
Mass Spectrometry an Effective Method to Detect Measurable Residual Disease in Multiple Myeloma Free
Anna Azvolinsky, PhD
February 26, 2025
Odronextamab Monotherapy Appears Safe, Effective in R/R DLBCL With Progression After CAR-T Free
Katie Robinson
February 26, 2025
Elderly Patients With BPDCN Respond Well to Venetoclax, Bortezomib, Dexamethasone Combination Free
Lara C. Pullen, PhD
February 26, 2025
Azacitidine Plus Venetoclax May Offer Path to HCT for Patients with High-Risk Treatment-Naïve Myelodysplastic Syndromes Free
Khylia Marshall
February 26, 2025
Telemedicine Approach Helps Improve IC-Based SCD Pain Management Free
Thomas R. Collins
February 26, 2025

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
May 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals